Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Equillium (EQ) EBITDA Margin (2022 - 2024)

Equillium (EQ) has disclosed EBITDA Margin for 3 consecutive years, with 114.07% as the latest value for Q4 2024.

  • On a quarterly basis, EBITDA Margin fell 8519.0% to 114.07% in Q4 2024 year-over-year; TTM through Sep 2025 was 549.73%, a 53867.0% decrease, with the full-year FY2024 number at 18.07%, up 1871.0% from a year prior.
  • EBITDA Margin was 114.07% for Q4 2024 at Equillium, down from 2.15% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 14797.25% in Q1 2022 to a low of 980.07% in Q4 2022.
  • A 3-year average of 1988.03% and a median of 25.9% in 2023 define the central range for EBITDA Margin.
  • Biggest YoY gain for EBITDA Margin was 95120bps in 2023; the steepest drop was -1483905bps in 2023.
  • Equillium's EBITDA Margin stood at 980.07% in 2022, then surged by 97bps to 28.88% in 2023, then plummeted by -295bps to 114.07% in 2024.
  • Per Business Quant, the three most recent readings for EQ's EBITDA Margin are 114.07% (Q4 2024), 2.15% (Q3 2024), and 2.14% (Q2 2024).